For diagnostic radiopharmaceuticals, the categories of proposed indications for use include, but are not limited to, the following:
Structure delineation;
Functional, physiological, or biochemical assessment;
Disease or pathology detection or assessment; and
Diagnostic or therapeutic patient management.
Where a diagnostic radiopharmaceutical is not intended to provide disease-specific information, the proposed indications for use may refer to a biochemical, physiological, anatomical, or pathological process or to more than one disease or condition.